logo
episode-header-image
Aug 2022
9m 32s

Podcast 300: NADIM II trial offers “quit...

NEJM Group
About this episode
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. We’re back with another interview from this year’s IASLC conference. This time, Christine Sadlowski and Dr. Julia Rotow interview Dr. Mariano Provencio about the survival outcomes from the NADIM II trial. In that trial, patients with resectable stage III AB non-small cell lung cancer received nivolumab p ... Show More
Up next
Aug 2022
Podcast 301: Monkeypox — what to look for, how to treat
<p>A VIDEO RECORDING OF THIS INTERVIEW IS <a href='https://cdn.jwplayer.com/players/DQOIo47Q-rmTFgmxB.html'>AVAILABLE HERE</a>.</p> <p>This time, we look to New York for guidance on recognizing and treating monkeypox.</p> <p>Dr. Eric Meyerowitz of Montefiore and Dr. Stephen Baum ... Show More
17m 28s
Aug 2022
Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial
<p>A VIDEO RECORDING OF THIS INTERVIEW <a href='https://cdn.jwplayer.com/players/oTVn3trC-rmTFgmxB.html'>IS AVAILABLE HERE</a>.</p> <p>Interim results on overall survival in phase 3 of the IMpower010 trial were presented at this year’s meeting of the International Assosciation fo ... Show More
14m 58s
Aug 2022
Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2
<p>A VIDEO RECORDING OF THIS INTERVIEW IS <a href='https://cdn.jwplayer.com/players/cn8xfSaw-rmTFgmxB.html'>AVAILABLE AT THIS LINK</a>.</p> <p>In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-day ... Show More
14m 8s
Recommended Episodes
Jun 2024
ASCO24: Transforming the Lung Cancer Treatment Landscape
<p class="paragraph" style= "margin: 0in; vertical-align: baseline;"><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Drs. Vamsi Velcheti and Nathan Pennell discuss novel approaches and key studies in lung cancer that were showcased at the 2024 ASCO Annu ... Show More
33m 17s
Apr 2024
A Revolution in Immunotherapy for Cervical and Endometrial Cancers
<p class="MsoNormal" style="margin: 11.0pt 0in 11.0pt 0in;"> <span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Doctors James Ferriss, Linda Duska, and Jayanthi Lea discuss the promise and the challenges of targeting the immune system with immune checkpoin ... Show More
26m 18s
Jun 2023
THOR, CONTACT-03, and Other Advances in GU Cancers at ASCO23
<div class="OutlineElement Ltr SCXW112417831 BCX0"> <p class="Paragraph SCXW112417831 BCX0"><span style= "font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;"> Drs. Rana McKay and Jonathan Rosen ... Show More
23m 25s
Feb 2024
Key Advances in Prostate, Kidney, and Bladder Cancers at GU24
<p>Drs. Neeraj Agarwal and Todd Morgan discuss CONTACT-02, KEYNOTE-564, CheckMate-67T, and other notable studies featured at the 2024 ASCO Genitourinary Cancers Symposium, as well as additional key abstracts in prostate, kidney, and bladder cancers that will significantly influen ... Show More
30m 6s
May 2024
Key Abstracts in GU Cancers at ASCO24
<p>Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss promising combination therapies and other compelling advances in genitourinary cancers in advance of the 2024 ASCO Annual Meeting.</p> <p><span style= "text-decoration: underline;"><strong>TRANSCRIPT</strong></span></p> <p ... Show More
26m 4s
Jan 2024
What's New in Prostate Cancer, RCC, and mUC at GU24
<p>Drs. Neeraj Agarwal and Jeanny Aragon-Ching discuss several key abstracts to be presented at the 2024 ASCO GU Cancers Symposium, including sequencing versus upfront combination therapies for mCRPC in the BRCAAway study, updates on the CheckMate-9ER and CheckMate-214 trials in ... Show More
25m 10s
May 2024
ASCO24: The Era of the ADCs in NSCLC
<p>Drs. Vamsi Velcheti and Nathan Pennell discuss key lung cancer abstracts from the 2024 ASCO Annual Meeting, including data from LUMINOSITY and ADAURA, novel therapies in KRASG12C-mutant advanced NSCLC, and the need for effective adjuvant therapies for patients with rare mutati ... Show More
26m 7s
May 2024
ASCO24: The Future of Personalized Immunotherapy
<p><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;"><span class="normaltextrun"> <span style= "line-height: 107%; color: black; background: white;">Dr. Diwakar Davar and Dr. Jason Luke discuss key abstracts from the 2024 ASCO Annual Meeting that explore ... Show More
34m 42s
Apr 2023
Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2023.1 Part 1
Dr. Dwight Owen is back on the ASCO Guidelines podcast, discussing the latest updates to the ASCO living guidelines for stage IV NSCLC. In Part 1, Dr. Owen presents the update for stage IV NSCLC without driver alterations. He reviews new evidence from EMPOWER-Lung3 and POSEIDON a ... Show More
11m 24s
May 2024
Exploring CAR T Cells in GI Cancers at ASCO24
<p><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;"><span class="normaltextrun"> <span style= "line-height: 107%; color: black; background: white;">Dr. Shaalan Beg and Dr.Mohamed Salem discuss key abstracts that will be presented at the 2024 ASCO Annual ... Show More
17m 58s
Listen to millions of songs and podcasts on Anghami